Viewing Study NCT01030861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:15 PM
Ignite Modification Date: 2025-12-27 @ 10:46 PM
Study NCT ID: NCT01030861
Status: COMPLETED
Last Update Posted: 2020-08-05
First Post: 2009-12-11
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Autoantibody Positive View
None Non-diabetic Relatives at Risk for Type 1 Diabetes View
None High Risk View
None Impaired Glucose Tolerance View
Keywords:

Keywords

Keyword Brief Keyword Text View
None type 1 diabetes View
None pre-diabetic View
None autoantibody positive View
None at risk for type 1 diabetes View
None glucose intolerance View
None relatives of people with type 1 diabetes View